# American Resources Corp: financial statements, quarterly

AREC · Nasdaq · CIK 1590715 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/arec.md) · [Financials](/companies/arec/financials.md) · [Filings](/companies/arec/filings.md) · [Insiders](/companies/arec/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/arec/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [8.9](/filings/0001477932-24-003233.md) | [2.0](/filings/0001477932-24-005119.md) | [5.8](/filings/0001477932-24-007457.md) | [(4.9) d](/filings/0001477932-25-007744.md) | [0.1](/filings/0001477932-25-007745.md) | [0.0](/filings/0001477932-24-005119.md) | [0.2](/filings/0001477932-25-008406.md) | [(0.3) d](/filings/0001477932-26-003317.md) | [0.0](/filings/0001477932-25-007745.md) | not reported | [0.0](/filings/0001477932-25-008406.md) | [(0.0) d](/filings/0001477932-26-003317.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | [1.0](/filings/0001477932-25-007745.md) | not reported | [0.4](/filings/0001477932-25-008406.md) | not reported | [0.2](/filings/0001477932-25-007745.md) | not reported | [0.1](/filings/0001477932-25-008406.md) | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(2.6)](/filings/0001477932-24-003233.md) | [(7.0)](/filings/0001477932-24-005119.md) | [1.1](/filings/0001477932-24-007457.md) | [(27.8) d](/filings/0001477932-25-007744.md) | [(6.7)](/filings/0001477932-25-007745.md) | [(6.2)](/filings/0001477932-24-005119.md) | [(8.8)](/filings/0001477932-25-008406.md) | [9.8 d](/filings/0001477932-26-003317.md) | [(5.0)](/filings/0001477932-25-007745.md) | not reported | [(4.4)](/filings/0001477932-25-008406.md) | [4.8 d](/filings/0001477932-26-003317.md) |
| Interest expense | $m | [0.6](/filings/0001477932-24-003233.md) | [0.2](/filings/0001477932-24-005119.md) | [0.3](/filings/0001477932-24-007457.md) | [0.9 d](/filings/0001477932-25-007744.md) | [0.7](/filings/0001477932-25-007745.md) | [0.4](/filings/0001477932-24-005119.md) | [2.0](/filings/0001477932-25-008406.md) | [2.4 d](/filings/0001477932-25-007744.md) | [1.8](/filings/0001477932-25-007745.md) | not reported | [2.0](/filings/0001477932-25-008406.md) | not reported |
| Net income | $m | [(2.9)](/filings/0001477932-24-007457.md) | [(8.5)](/filings/0001477932-24-007457.md) | [(2.5)](/filings/0001477932-24-007457.md) | [(38.7) d](/filings/0001477932-25-007744.md) | [(7.0)](/filings/0001477932-25-007745.md) | [(7.0)](/filings/0001477932-24-007457.md) | [(10.6)](/filings/0001477932-25-008406.md) | [(10.4) d](/filings/0001477932-26-003317.md) | [(6.7)](/filings/0001477932-25-007745.md) | [(8.7)](/filings/0001477932-25-008406.md) | [(7.7)](/filings/0001477932-25-008406.md) | [78.4 d](/filings/0001477932-26-003317.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | [(0.09)](/filings/0001477932-25-007745.md) | not reported | [(0.14)](/filings/0001477932-25-008406.md) | not reported | [(0.08)](/filings/0001477932-25-007745.md) | not reported | [(0.05)](/filings/0001477932-25-008406.md) | not reported |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted

## Balance sheet

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | [1.3](/filings/0001477932-25-007744.md) | not reported | [0.6](/filings/0001477932-24-005119.md) | [0.8](/filings/0001477932-24-007457.md) | [0.2](/filings/0001477932-26-003317.md) | [0.0](/filings/0001477932-25-007745.md) | not reported | [2.1](/filings/0001477932-25-008406.md) | [31.7](/filings/0001477932-26-003317.md) |
| Current assets | $m | [5.7](/filings/0001477932-23-003561.md) | [6.4](/filings/0001477932-23-006093.md) | [12.4](/filings/0001477932-23-008446.md) | [37.8](/filings/0001477932-25-007744.md) | [4.8](/filings/0001477932-24-003233.md) | [4.5](/filings/0001477932-24-005119.md) | [5.7](/filings/0001477932-24-007457.md) | [92.9](/filings/0001477932-26-003317.md) | [8.6](/filings/0001477932-25-007745.md) | not reported | [8.4](/filings/0001477932-25-008406.md) | [134](/filings/0001477932-26-003317.md) |
| Total assets | $m | [49.5](/filings/0001477932-23-003561.md) | [100](/filings/0001477932-23-006093.md) | [103](/filings/0001477932-23-008446.md) | [64.7](/filings/0001477932-25-007744.md) | [216](/filings/0001477932-24-003233.md) | [196](/filings/0001477932-24-005119.md) | [212](/filings/0001477932-24-007457.md) | [282](/filings/0001477932-26-003317.md) | [204](/filings/0001477932-25-007745.md) | not reported | [202](/filings/0001477932-25-008406.md) | [169](/filings/0001477932-26-003317.md) |
| Current liabilities | $m | [21.8](/filings/0001477932-23-003561.md) | [16.2](/filings/0001477932-23-006093.md) | [16.2](/filings/0001477932-23-008446.md) | [78.3](/filings/0001477932-25-007744.md) | [16.0](/filings/0001477932-24-003233.md) | [19.3](/filings/0001477932-24-005119.md) | [24.6](/filings/0001477932-24-007457.md) | [166](/filings/0001477932-26-003317.md) | [86.0](/filings/0001477932-25-007745.md) | not reported | [84.8](/filings/0001477932-25-008406.md) | [61.2](/filings/0001477932-26-003317.md) |
| Total liabilities | $m | [42.1](/filings/0001477932-23-003561.md) | [89.3](/filings/0001477932-23-006093.md) | [88.2](/filings/0001477932-23-008446.md) | [110](/filings/0001477932-25-007744.md) | [236](/filings/0001477932-24-003233.md) | [241](/filings/0001477932-24-005119.md) | [266](/filings/0001477932-24-007457.md) | [363](/filings/0001477932-26-003317.md) | [289](/filings/0001477932-25-007745.md) | not reported | [297](/filings/0001477932-25-008406.md) | [75.7](/filings/0001477932-26-003317.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001477932-26-003317.md) | not reported | not reported | [1.0](/filings/0001477932-25-008406.md) | [1.0](/filings/0001477932-26-003317.md) |
| Current portion of debt | $m | [0.8](/filings/0001477932-23-003561.md) | [0.8](/filings/0001477932-23-006093.md) | [0.8](/filings/0001477932-23-008446.md) | [2.1](/filings/0001477932-25-007744.md) | [0.8](/filings/0001477932-24-003233.md) | [0.8](/filings/0001477932-24-005119.md) | [0.8](/filings/0001477932-24-007457.md) | [2.1](/filings/0001477932-25-008406.md) | [2.1](/filings/0001477932-25-007745.md) | not reported | [1.5](/filings/0001477932-25-008406.md) | not reported |
| Shareholders' equity | $m | [7.3](/filings/0001477932-23-008446.md) | [10.7](/filings/0001477932-23-008446.md) | [14.7](/filings/0001477932-23-008446.md) | [(43.5)](/filings/0001477932-25-007744.md) | [(52.2)](/filings/0001477932-25-008406.md) | [(44.1)](/filings/0001477932-24-005119.md) | [(51.8)](/filings/0001477932-24-007457.md) | [(79.4)](/filings/0001477932-26-003317.md) | [(84.1)](/filings/0001477932-25-007745.md) | [(91.3)](/filings/0001477932-25-008406.md) | [(80.7)](/filings/0001477932-25-008406.md) | [94.8](/filings/0001477932-26-003317.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent, us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q4 FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q4 FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(3.9) d](/filings/0001477932-23-008446.md) | [14.4 d](/filings/0001477932-24-002122.md) | [(7.3)](/filings/0001477932-24-003233.md) | [0.7 d](/filings/0001477932-24-005119.md) | [0.8 d](/filings/0001477932-24-007457.md) | [(13.7) d](/filings/0001477932-25-007744.md) | [(4.8)](/filings/0001477932-25-007745.md) | [(8.5) d](/filings/0001477932-24-005119.md) | [(4.3) d](/filings/0001477932-25-008406.md) | [(3.7) d](/filings/0001477932-25-007744.md) | [(1.4)](/filings/0001477932-25-007745.md) | [(1.0) d](/filings/0001477932-26-003317.md) |
| Capital expenditure | $m | not reported | not reported | [0.5](/filings/0001477932-23-003561.md) | [(0.5) d](/filings/0001477932-24-005119.md) | [3.5 d](/filings/0001477932-24-007457.md) | [0.1 d](/filings/0001477932-25-007744.md) | not reported | not reported | [(0.5) d](/filings/0001477932-24-007457.md) | [0.9 d](/filings/0001477932-25-007744.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities, us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q1 FY2024 (2024-03-31) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q3 FY2025 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [76.4](/filings/0001477932-25-007745.md) | [77.4](/filings/0001477932-25-008406.md) | [79.0](/filings/0001477932-25-007745.md) | [84.3](/filings/0001477932-25-008406.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 106,971,272 at 2026-05-19, from the cover of the [10-K filed 2026-05-20](/filings/0001477932-26-003317.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.